Prevalence and characteristics of diabetic polyneuropathy in Passo Fundo, South of Brazil

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 6, 2007, Pages 987-992

  Tres, Gláucia Sarturi ^a   Kurtz Lisbôa, Hugo R ^a,d   Syllos, Roger ^b   Canani, Luis Henrique ^c   Gross, Jorge Luiz ^c  

^a UNIVERSITY OF PASSO FUNDO   (Brazil)

^b Institute of Ophthalmology of Passo Fundo   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d NONE   (Brazil)

Author keywords

Diabetic complications; Diabetic neuropathy; Type 2 diabetes mellitus

Indexed keywords

EID: 35848938171     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302007000600014     Document Type: Article

References (25)

1. Sheerwin R. Diabetes mellitus. In: Goldman L, Bennett JC (eds). Cecil Textbook of Medicine. Philadelphia: WB Saunders, 2000. pp. 1263-85.
2. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2001;24(1):S5-20.
3. Fauci AS, Braunwald E, Isselbacher KJ, Kasper DL, Hauser SL, Longo DL, et al. Late Complications of Diabetes. New York: McGraw-Hill, 2001.
4. Associação Latinoamericana de Diabetes. Consenso ALAD. Prevenção, controle e tratamento do diabetes não insulinodependente. ALAD, 1995.
5. Malerbi DA, Franco LJ. The Brazilian Cooperative Group on the study on diabetes prevalence. Multicenter study of the prevalence of diabetes mellitus and impaired glucose in the urban Brazilian population aged 30-69 years. Diabetes Care 1992;15:1509-16.
6. American Diabetes Association, American Academy of Neurology. Consensus statement report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes Care 1988;11:592-7.
7. Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet 2003;361:1545-51.
8. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978;1:168-88, 252-63.
9. Grimaldi A, Grange V, Allannic H, Passa P, Rodier M, Cornet P, et al. Epidemiological analysis of patient with type 2 diabetes in France. J Diabetes Complications 2000;14:247-9.
10. Jaspan JB, Green AJ. The neuropathies of diabetes. In: DeGroot LJ, Besser M (eds). Endocrinology. Philadelphia: WB Saunders, 1995. p. 1545.
11. Boulton AJ. Guidelines for diagnosis and outpatient management of diabetic peripheral neuropathy. European Association for the Study of Diabetes, Neurodiab. Diabetes Metab 1998;24(suppl 3):55-65.
12. Stevens MJ, Feldman EL, Greene DA. The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabet Med 1995;12:566-79.
13. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1996;17:1281-9.
14. Kandel ER, Schwartz JH, Jessel TM. Principles of neurology science. In: Dumitru D. Electrodiagnostic Medicine. New York: McGraw-Hill, 2000. pp. 730-1.
15. Rose G, Blackburn H, Gillum R, Prineas R. Cardiovascular survey methods. WHO Monograph Series 1982;56:123-9.
16. Zelmanovitz T, Gross JL, Oliveira J, Azevedo MJ. Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy. Diabetes Care 1998;21:1076-9.
17. Comi G, Corbo M. Metabolic neuropathies. Curr Opin Neurol 1998;11(5):523-9.
18. Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy and cardiovascular disease in NIDDM. Diabetes Care 1996;19:1243-8.
19. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complications study. Diabetologia 1996;39:1377-84.
20. Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H. Albuminuria and poor glycaemic control predict mortality in NIDDM. Diabetes 1995;44:1303-9.
21. Janka HU, Warram JH, Rand LJ, Krolewski AS. Risk factors for the progression of background retinopathy in long standing IDDM. Diabetes 1989;38:460-4.
22. Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis 2003;45(5):405-13.
23. Jaspan JB, Green AJ. The neuropathies of diabetes. In: DeGroot LJ, Besser M, Burguer HG, Jameson JL, Loriaux DL, Marshall JC, et al. (eds). Endocrinology. 3rd ed. Philadelphia: WB Saunders, 1995. pp. 1536-68.
24. Costa LA, Canani LH, Lisboa HR, Tres GS, Gross JL. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes. Diabet Med 2004;21(3):252-5.
25. Carrington AL, Shaw JE, Van Schie CH, Abbott CA, Vileikyte L, Boulton AJ. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care 2002;25(11):2010-5.